DUBLIN–(BUSINESS WIRE)–The “Global Drug Delivery Devices Market (2021-2026) by device type, route of administration, application, end-user, vehicle outlook, Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Drug Delivery Devices Market is estimated to be USD 22.2 Bn in 2021 and is expected to reach USD 28.7 Bn by 2026, growing at a CAGR of 5.3%.
Key factors, such as the rising geriatric population coupled with increasing chronic ailments such as diabetes, cancer, etc have led to a growth in drug delivery devices. The surge in non-communicable diseases has also led to the demand for non-invasive drug delivery methods. Additionally, the growth of biologics is significantly contributing to the drug delivery device market.
However, factors such as drug recalls and biocompatibility issues with increased side effects are likely to restrain the market growth of drug delivery devices. Moreover, the time taken for approval of novel drugs is also likely to hamper the growth of drug delivery devices due to the subsequent delay in deliveries.
Company Profiles
Some of the companies covered in this report are 3M Company, AstraZeneca PLC, Becton, Dickinson, Boehringer Ingelheim group, GlaxoSmithKline plc, Insulet Corporation, Medtronic Plc, Sulzer Ltd. and West Pharmaceuticals Services, Inc.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Drug Delivery Devices Market.
- The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
- The report also contains the competitive analysis using Competitive Quadrant, the analyst’s proprietary competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Growing geriatric population and rising ailments
4.2.1.2 Increasing demand for non-invasive drug-delivery methods
4.2.1.3 Growth in the biologics markets
4.2.2 Restraints
4.2.2.1 High cases of drug recalls
4.2.2.2 Biocompatibility issues
4.2.2.3 High time taken for approval of novel drugs
4.2.3 Opportunities
4.2.3.1 Growth in Nanotechnology and technological advancements
4.2.3.2 Growing R&D investments
4.2.4 Challenges
4.2.4.1 Inefficiencies in delivering poorly soluble drugs
4.2.4.2 Lack of trained professionals to administer the drugs
4.3 Trends
5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Drug Delivery Device Market, By Device Type
6.1 Introduction
6.2 Smart Pills
6.3 Inhalers
6.4 Drug Eluting Stents
6.5 Safety Syringes
6.6 Implantable Drug Delivery Device
6.7 Transdermal Patches
6.8 Others
7 Global Drug Delivery Devices Market, By Route of Administration
7.1 Introduction
7.2 Oral
7.3 Inhalation
7.4 Transdermal
7.5 Injectable
7.6 Ocular
7.7 Nasal
7.8 Topical
7.9 Others
8 Global Drug Delivery Devices Market, By Application
8.1 Introduction
8.2 Oncology
8.3 Infectious Diseases
8.4 Respiratory Diseases
8.5 Diabetes
8.6 Cardiovascular Diseases
8.7 Autoimmune Diseases
8.8 Central Nervous System Disorders
8.9 Others
9 Global Drug Delivery Devices Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Diagnostic Centers
9.4 Ambulatory Surgery Centers/Clinics
9.5 Home Care Settings
9.6 Others
10 Global Drug Delivery Devices Market, By Vehicles Outlook
11 Global Drug Delivery Devices Market, By Geography
11.1 Introduction
11.2 North America
11.3 South America
11.4 Europe
11.5 Asia-Pacific
11.6 Rest of the World
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Mergers & Acquisitions
12.3.2 Agreement, Collaborations, & Partnerships
12.3.3 New Product Launches & Enhancements
12.3.4 Investments & Funding
13 Company Profiles
13.1 Pfizer, Inc
13.2 Johnson & Johnson Services, Inc
13.3 F. Hoffmann-La Roche, Ltd
13.4 Novartis AG
13.5 3M
13.6 Bayer AG
13.7 uniQure N.V.
13.8 Shenzhen (SiBiono) GeneTech Co. Ltd (Hubei Tongji Benda Ebei Pharmaceuticals)
13.9 Antares Pharma, Inc
13.10 GlaxoSmithKline plc
13.11 AstraZeneca PLC
13.12 Becton Dickinson
13.13 Boehringer Ingelheim group
13.14 Consort Medical plc (Recipharm Group)
13.15 Insulet Corporation
13.16 Medtronic Plc
13.17 Sulzer Ltd.
13.18 West Pharmaceuticals Services, Inc
13.19 Generex Biotechnology
13.20 Panacea Pharmaceuticals Inc.
13.21 Aptar Pharma
13.22 Koninklijke Philips N.V.
13.23 Nemera
13.24 Biocorp Production.
13.25 Eli Lilly and Co.
14 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/tu4pd4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
